Hudson Bay Capital Management
RDY icon

Hudson Bay Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Hudson Bay Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-75,000
Closed -$609K – 566
2019
Q4 		$609K Hold
75,000
– – 0.01% 338
2019
Q3 		$568K Hold
75,000
– – 0.02% 342
2019
Q2 		$562K Hold
75,000
– – 0.01% 347
2019
Q1 		$608K Buy
+75,000
New +$570K 0.01% 597

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aperio Group
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Hudson Bay Capital Management's RDY Position: Q1 2020 in Review

Hudson Bay Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2020, closing a stake of 75,000 shares — an estimated $609K sold.

Hudson Bay Capital Management first reported a position in RDY in Q1 2019 and held it in 4 quarters. The position peaked at $609K in Q4 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q1 2020.

  • Hudson Bay Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 75,000 Dr. Reddy's Laboratories shares in Q1 2020, an estimated $609K.
  • Hudson Bay Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 4 quarters.
  • Hudson Bay Capital Management's Dr. Reddy's Laboratories position peaked at $609K in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2020.

Based on Hudson Bay Capital Management's 13F filing for Q1 2020, filed 14 May 2020.